Fierce Pharma Engage 2025

Roundtables: Interactive small group discussions - 3 rotations (30 minutes each)
We will have several different topics that attendees can select between and have an open discussion with a group leader to help facilitate the conversation. Then after 30 minutes, we will rotate, and attendees can select another topic and small group and have an open discussion and network with peers.

• 30 minutes per group; 5 minutes to transition between groups
• Roundtable 1 – 9:05 – 9:35 am
• Roundtable 2 – 9:40 – 10:10 am
• Roundtable 3 – 10:15 – 10: 45 am
• Groups capped at 15 people including the moderator.

Topics:

• 1. Investor Relations: Metrics, Challenges, and Collaborative Solutions- Aron Feingold, Vice President, Investor Relations and Corporate Communications, Geron Corporation 
  2. Building the Workforce of Tomorrow: Attracting, Retaining, and Empowering Talent- Sarah Thailing, Senior Director, Investor Relations & Corporate Communications, Poseida Therapeutics  
  3. Maximizing Impact as an N of 1: Communication Strategies for Solo Professionals in Biotech- Debbie Etchison, Executive Director, Head of Corporate Affairs, Alkeus Pharmaceuticals, Inc 
  4. Strategic Corporate Communications for Small Organizations: Maximizing Impact with Limited Resources -Hope Mueller, SVP, Corporate Development and Strategy, Curavax 
  5. Navigating Digital Trends: Maximizing Social Media and Emerging Tech in Pharma Communications- Colby Accola, Senior Manager, Communications & Patient Advocacy, North America, Incyte 
  6. Navigating Change: Communicating Through Organizational Growth, Product Launches, and Market Disruptions - Amanda Sheldon, head of corporate communications, Arcutis